Leo, BAS, IMHO we are very fortunate to working with a well organized and motivated Patient Organization like the Rett Syndrome Foundation. They have designated the 14 Clinical Research Centers of Excellence that have conducted the multi-year Natural History Study which will be invaluable to our P2. Those Centers will have been at the core of other trials such as the IGF-1 trial and the Neuren "Trofinetide" P2 and no doubt will play a role in the 2-73 trial. Dr Kaminsky and the associated researchers for the RSF will be doing everything in their power to make our trial a success. I know that our people are getting a warm and enthusiastic welcome at these COE's.
We may be impatient as Anavex shareholders but that impatience pales in comparison to the families of these afflicted girls.
Market Data 
Markets 
AI
